0001581990 false PLAINS GP HOLDINGS LP 0001581990 2019-09-17 2019-09-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)September 18, 2019

 

Plains GP Holdings, L.P.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation)
  1-36132
(Commission File Number)
  90-1005472
(IRS Employer Identification No.)

 

333 Clay Street, Suite 1600, Houston, Texas 77002

(Address of principal executive offices) (Zip Code)

 

713-646-4100

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨                       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨                       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨                       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨                       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Shares   PAGP   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 
Registrant Name

 

 

 

ITEM 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Pursuant to the Third Amended and Restated Limited Liability Company Agreement of PAA GP Holdings LLC, as amended (the “PAGP GP LLC Agreement”), Oxy Holding Company (Pipeline), Inc. (“Oxy”) had the right to designate a director to PAA GP Holdings LLC’s (“PAGP GP”) board of directors for as long as it owned at least a 10% Qualifying Interest (as that term is defined in the PAGP GP LLC Agreement). Effective upon the closing of the Concurrent Secondary Offerings (as defined below) on September 23, 2019, Oxy will cease to own a Qualifying Interest and therefore no longer will have a PAGP GP board designation right. Accordingly, pursuant to Section 6.1(a)(iv) of the PAGP GP LLC Agreement, Oscar K. Brown, Oxy’s PAGP GP board designee, will automatically cease to be a member of the PAGP GP board.

 

ITEM 8.01Other Events.

 

On September 18, 2019, Plains GP Holdings, L.P. (“PAGP”), PAGP GP and Oxy entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc. relating to the offering and sale (the “PAGP Secondary Offering”) by Oxy of 15,000,000 Class A shares representing limited partner interests in PAGP (“Class A shares”). The closing of the PAGP Secondary Offering is expected to occur on September 23, 2019.

 

The Class A shares will be offered and sold under the PAGP shelf registration statement on Form S-3 (Registration No. 333-200596) filed with the Securities and Exchange Commission on November 26, 2014 (the “Registration Statement”), and are described in a Prospectus Supplement dated September 18, 2019 to the Prospectus dated December 10, 2014, which is included in the Registration Statement.

 

The closing of the offering and sale by Oxy of 14,977,890 common units representing limited partner interests in Plains All American Pipeline, L.P. in a concurrent underwritten public offering (together with the PAGP Secondary Offering, the “Concurrent Secondary Offerings”) is also expected to occur on September 23, 2019.

 

The foregoing description of the PAGP Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement. A copy of the PAGP Underwriting Agreement is filed herewith as Exhibit 1.1 and is also incorporated by reference herein.

 

ITEM 9.01Financial Statements and Exhibits

 

(d)       Exhibits.

 

Exhibit
Number
  Description
1.1   Underwriting Agreement, dated September 18, 2019, by and among Plains GP Holdings, L.P., PAA GP Holdings LLC, Oxy Holding Company (Pipeline), Inc. and Barclays Capital Inc.
5.1   Opinion of Vinson & Elkins L.L.P. regarding legality of the Class A shares.
8.1   Opinion of Vinson & Elkins L.L.P. regarding tax matters.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLAINS GP HOLDINGS, L.P.   
   
Date:  September 23, 2019 By: PAA GP Holdings LLC, its general partner
     
  By: /s/ Richard McGee
  Name: Richard McGee  
  Title: Executive Vice President

 

3